KRT8 antibody
Quick Overview for KRT8 antibody (ABIN7249764)
Target
See all KRT8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Characteristics
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogen
- KLH conjugated Synthetic peptide corresponding to Mouse Cytokeratin 8
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:2000, IHC 1:200-1:800
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 430 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 1 % BSA and 50 % glycerol, pH 7.4
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KRT8 (Keratin 8 (KRT8))
-
Alternative Name
- CK-8
-
Background
- Cytokeratin 8 (CK8) has a molecular weight of 52.5 KDa, which belongs to the HMW (high molecular weight) B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.
-
Molecular Weight
-
Observed_MW: 54 kDa
Calculated_MW: 54 kDa
-
UniProt
- P05787, P11679, Q10758
Target
-